LYNN MATRISIAN was named the inaugural chief research officer for the Pancreatic Cancer Action Network. Matrisian was promoted from vice president of scientific and medical affairs, where she has served since 2011. Doug Laidlaw was named vice president of scientific and medical affairs, and will be responsible for overseeing the nonprofit’s research grants, patient services...
The FDA Oncologic Drugs Advisory Committee July 25 voted unanimously to set more rigorous standards for new trials for approval of perioperative indications of cancer drugs.
